Association of Polymorphisms in the Androgen Receptor Gene and Finasteride Response in Women With Androgenetic Alopecia

计划入组 12 人 · 首次发布于 2010 年 1 月 20 日

The CAG Bipolar the CAG Bipolar RCT

计划入组 1,000 人 · 首次发布于 2020 年 1 月 18 日

Microalbuminuria Predicting CIAKI After CAG

计划入组 800 人 · 首次发布于 2016 年 6 月 22 日

VO659

Repeat expansion disorders therapeutics(Triplet Therapeutics, Inc.)

triplet repeat modulator (myotonic dystrophy type 1)

JOHN RENEAU

United States

AMERICAN REGENT, INC.

United States

REPHA GmbH Biologische Arzneimittel

Germany

Vico Therapeutics' VO659 Shows Promise in Huntington's Disease and Spinocerebellar Ataxias

Early Huntington's Disease Brain Changes Linked to Somatic CAG Expansion

Vico Therapeutics Advances VO659 with Twice-Annual Dosing in Phase 1/2 Trial for Huntington's Disease and Spinocerebellar Ataxias